Ubs Group Ag INTERCEPT PHARMACEUTICALS IN Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	N/A	-7,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	N/A	1,000 Added 16.67%	7,000 $5,000
Q2 2020 Jul 31, 2020	BUY	N/A	6,000 New	6,000 $5,000
Q1 2019 May 14, 2019	SELL	N/A	-2,218,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	N/A	-3,750,000 Reduced 62.84%	2,218,000 $2.04 Million
Q3 2018 Nov 14, 2018	SELL	N/A	-2,000,000 Reduced 25.1%	5,968,000 $6.03 Million
Q2 2018 Aug 14, 2018	BUY	N/A	739,000 Added 10.22%	7,968,000 $6.98 Million
Q1 2018 May 15, 2018	BUY	N/A	4,949,000 Added 217.06%	7,229,000 $5.79 Million
Q4 2017 Feb 14, 2018	BUY	N/A	900,000 Added 65.22%	2,280,000 $1.81 Million
Q3 2017 Nov 14, 2017	SELL	N/A	-3,668,000 Reduced 72.66%	1,380,000 $1.07 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-3,002,000 Reduced 37.29%	5,048,000 $4.91 Million
Q1 2017 Nov 14, 2017	BUY	N/A	8,050,000	8,050,000 $7.5 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.